BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31357410)

  • 1. Integrated Systems Pharmacology, Urinary Metabonomics, and Quantitative Real-Time PCR Analysis to Uncover Targets and Metabolic Pathways of the You-Gui Pill in Treating Kidney-Yang Deficiency Syndrome.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the biomarkers and therapeutic mechanism of kidney-yang deficiency syndrome treated by You-gui pill using systems pharmacology and serum metabonomics.
    Chen R; Wang J; Liao C; Zhang L; Guo Q; Wang X
    RSC Adv; 2018 Jan; 8(2):1098-1115. PubMed ID: 35539000
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Feng Q; Tong L; Lu Q; Liu S; Zhao L; Xiong Z
    Anal Biochem; 2022 Apr; 643():114580. PubMed ID: 35149001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinmedomics strategy to discover effective constituents and elucidate action mechanism of Nanshi capsule against kidney-yang deficiency syndrome].
    Liu Q; Zhao HW; Zhang AH; Sun H; Zhao XH; Nan Y; Kong L; Guan Y; Zou SY; Ma ZH; Wang XJ
    Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(15):2901-2914. PubMed ID: 28914036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated UHPLC-MS untargeted metabolomics and gut microbe metabolism pathway-targeted metabolomics to reveal the prevention mechanism of Gushudan on kidney-yang-deficiency-syndrome rats.
    Xin L; Ren M; Lou Y; Yin H; Qin F; Xiong Z
    J Pharm Biomed Anal; 2024 May; 242():116062. PubMed ID: 38387127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention.
    Zhang A; Liu Q; Zhao H; Zhou X; Sun H; Nan Y; Zou S; Ma CW; Wang X
    Sci Rep; 2016 Jan; 6():19333. PubMed ID: 26785698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic profiling reveals therapeutic biomarkers of processed Aconitum carmichaeli Debx in treating hydrocortisone induced kidney-yang deficiency syndrome rats.
    Tan Y; Liu X; Lu C; He X; Li J; Xiao C; Jiang M; Yang J; Zhou K; Zhang Z; Zhang W; Lu A
    J Ethnopharmacol; 2014 Mar; 152(3):585-93. PubMed ID: 24556226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated adrenal and testicular metabolomics revealed the protective effects of Guilingji on the Kidney-Yang deficiency syndrome rats.
    Du K; Gao XX; Feng Y; Li J; Wang H; Lv SL; Wang PY; Zhang B; Qin XM
    J Ethnopharmacol; 2020 Jun; 255():112734. PubMed ID: 32151756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating strategies of metabolomics, network pharmacology, and experiment validation to investigate the processing mechanism of Epimedium fried with suet oil to warm kidney and enhance yang.
    Sun E; Huang R; Ding K; Wang L; Hou J; Tan X; Wei Y; Feng L; Jia X
    Front Pharmacol; 2023; 14():1113213. PubMed ID: 36762111
    [No Abstract]   [Full Text] [Related]  

  • 11. Study on the intervention effect of Epimedium before and after suet-oil-processed on kidney yang deficiency rats based on intestinal flora and fecal metabolomics.
    Huang R; Chen Z; Ding K; Sun E; Huang Y; Wei Y; Jia X
    J Pharm Biomed Anal; 2024 Mar; 240():115957. PubMed ID: 38181555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics and serum pharmacochemistry revealed the preventive mechanism of Gushudan in kidney-yang-deficiency-syndrome rats.
    Lu Q; Feng Q; Yu J; Tong L; Zhang J; Sun J; Zhao J; Xiong Z
    Biomed Chromatogr; 2023 Mar; 37(3):e5569. PubMed ID: 36527197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 16S rDNA sequencing combined with metabolomics profiling with multi-index scoring method reveals the mechanism of salt-processed Semen Cuscuta in Bushen Antai mixture on kidney yang deficiency syndrome.
    Xu B; Yang Z; Zhang X; Liu Z; Huang Y; Ding X; Chu J; Peng T; Wu D; Jin C; Li W; Cai B; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123602. PubMed ID: 36652816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined systems pharmacology and fecal metabonomics to study the biomarkers and therapeutic mechanism of type 2 diabetic nephropathy treated with
    Chen R; Liao C; Guo Q; Wu L; Zhang L; Wang X
    RSC Adv; 2018 Jul; 8(48):27448-27463. PubMed ID: 35540008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel chinmedomics strategy for discovering effective constituents from ShenQiWan acting on ShenYangXu syndrome.
    Zhou XH; Zhang AH; Wang L; Tan YL; Guan Y; Han Y; Sun H; Wang XJ
    Chin J Nat Med; 2016 Aug; 14(8):561-81. PubMed ID: 27608946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the substance basis of the efficacy of eucommiae cortex before and after salt processing for the treatment of kidney-yang deficiency syndrome based on the spectrum-effect relationship.
    Wu H; Lv Y; Zhao M; Tang R; Li Y; Fang K; Wei F; Ge W; Du W; Li C; Zhang Y
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116926. PubMed ID: 37479066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum metabolomics strategy for understanding pharmacological effects of ShenQi pill acting on kidney yang deficiency syndrome.
    Nan Y; Zhou X; Liu Q; Zhang A; Guan Y; Lin S; Kong L; Han Y; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():217-226. PubMed ID: 26747643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. You-gui Pill ameliorates renal tubulointerstitial fibrosis via inhibition of TGF-β/Smad signaling pathway.
    Wang L; Cao AL; Chi YF; Ju ZC; Yin PH; Zhang XM; Peng W
    J Ethnopharmacol; 2015 Jul; 169():229-38. PubMed ID: 25922264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined
    Tong L; Feng Q; Lu Q; Zhang J; Xiong Z
    J Pharm Biomed Anal; 2022 Aug; 217():114843. PubMed ID: 35623116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China.
    Jiang N; Liu HF; Li SD; Zhou WX; Zhang YX; Zhang Q; Yan XZ
    Acta Pharmacol Sin; 2015 Jun; 36(6):689-98. PubMed ID: 25937635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.